Song BioTechnologies

Song BioTechnologies is an emerging biotechnology company focused on the discovery and development of novel therapeutic agents for autoimmune diseases and oncology. The company utilizes its proprietary SongBio Discovery Platform to identify high-affinity small molecules and biologics targeting key inflammatory pathways. Their current research efforts are centered on modulating cytokine signaling to address unmet needs in chronic inflammatory conditions such as psoriasis and rheumatoid arthritis. By leveraging advanced computational modeling and high-throughput screening, Song BioTechnologies aims to accelerate the transition of innovative candidates from the laboratory to clinical evaluation.